VOR.NASDAQVor Biopharma INC

SCHEDULE: VOR Biopharma Insider Reduces Stake to 21.9%

Sentiment:

Beneficial Ownership Amendment

📋All filings for Vor Biopharma INC
🔒Login to Follow

Reprogrammed Interchange LLC and Reid Hoffman significantly reduced their beneficial ownership in VOR Biopharma Inc. through open market sales, now holding 21.9% of common stock.

Worse than expectedThe filing details significant insider selling by a major beneficial owner, Reprogrammed Interchange LLC, and Reid Hoffman, reducing their stake by more than one percent of the outstanding shares.Insider selling, especially by a substantial holder, is generally perceived as a negative signal regarding the company's near-term prospects or valuation.

Summary

  • Reprogrammed Interchange LLC and Reid Hoffman, as Reporting Persons, filed Amendment No. 5 to their Schedule 13D for VOR Biopharma Inc.
  • The Reporting Persons collectively beneficially own 1,498,921 shares of VOR Biopharma Inc. common stock, representing 21.9% of the class.
  • Reprogrammed Interchange LLC sold 70,763 shares on October 6, 2025, at a weighted average price of $37.0079 per share.
  • An additional 27,624 shares were sold on October 7, 2025, at a weighted average price of $33.8369 per share.
  • These sales between October 6-7, 2025, resulted in a decrease in beneficial ownership by more than one percent of the outstanding common stock.
  • Further sales by Reprogrammed Interchange LLC were reported from August 25, 2025, through October 3, 2025, with prices ranging from $30.8023 to $42.3256 per share.
  • All share amounts and weighted average sale prices from August 25, 2025, through September 16, 2025, reflect a 1-for-20 reverse stock split effected on September 18, 2025.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the consistent and significant insider selling by a major beneficial owner, which typically signals a lack of confidence or a belief that the stock is fully valued or overvalued.

Negatives

  • Significant insider selling by a major beneficial owner, Reprogrammed Interchange LLC, and Reid Hoffman, which can be perceived negatively by the market.
  • The reduction in beneficial ownership by more than one percent of outstanding shares signals a decreased stake and potentially reduced confidence from a key investor.
  • The sales occurred across a range of prices, including recent sales at $37.0079 and $33.8369, indicating a consistent divestment strategy.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders may interpret the significant insider selling as a negative indicator, potentially leading to decreased investor confidence and selling pressure on the stock.
  • The reduction in a major holder's stake could diminish institutional support or influence on the company's strategic direction.

Key Dates

DateDescription
January 7, 2025Original Schedule 13D filed with the SEC.
August 25, 2025Reprogrammed Interchange LLC sold 19,367 shares at $42.3256.
August 26, 2025Reprogrammed Interchange LLC sold 14,209 shares at $41.6165.
August 27, 2025Reprogrammed Interchange LLC sold 30,582 shares at $40.1057.
August 28, 2025Reprogrammed Interchange LLC sold 40,317 shares at $40.2307.
August 29, 2025Amendment No. 1 to Schedule 13D filed with the SEC.
September 3, 2025Reprogrammed Interchange LLC sold 27,730 shares at $39.9222.
September 4, 2025Reprogrammed Interchange LLC sold 22,650 shares at $38.5709.
September 5, 2025Reprogrammed Interchange LLC sold 20,000 shares at $39.3639.
September 8, 2025Reprogrammed Interchange LLC sold 23,221 shares at $39.7949.
September 9, 2025Reprogrammed Interchange LLC sold 22,461 shares at $40.0084; Amendment No. 2 to Schedule 13D filed with the SEC.
September 10, 2025Reprogrammed Interchange LLC sold 17,500 shares at $36.3019.
September 11, 2025Reprogrammed Interchange LLC sold 14,240 shares at $36.6151.
September 12, 2025Reprogrammed Interchange LLC sold 15,000 shares at $35.0811; Amendment No. 3 to Schedule 13D filed with the SEC.
September 15, 2025Reprogrammed Interchange LLC sold 20,000 shares at $32.815.
September 16, 2025Reprogrammed Interchange LLC sold 22,363 shares at $30.8023.
September 18, 20251-for-20 reverse stock split of VOR Biopharma Inc. Common Stock effected.
October 1, 2025Reprogrammed Interchange LLC sold 1,400 shares at $39.1925.
October 2, 2025Reprogrammed Interchange LLC sold 32,451 shares at $39.828.
October 3, 2025Reprogrammed Interchange LLC sold 7,901 shares at $37.832.
October 6, 2025Date of event requiring filing of this statement; Reprogrammed Interchange LLC sold 70,763 shares at $37.0079; Amendment No. 4 to Schedule 13D filed with the SEC.
October 7, 2025Reprogrammed Interchange LLC sold 27,624 shares at $33.8369.
October 8, 2025Amendment No. 5 to Schedule 13D signed and filed.

Recommendation

sell

The consistent and significant selling by a major beneficial owner, Reprogrammed Interchange LLC and Reid Hoffman, suggests a lack of conviction in the company's future performance or a belief that the stock is currently overvalued. Such insider divestment often precedes periods of underperformance or reflects a negative outlook, making a 'sell' recommendation prudent for investors.

Keywords

VOR Biopharma, Schedule 13D, Insider Selling, Share Sale, Reid Hoffman, Reprogrammed Interchange LLC, Beneficial Ownership, Common Stock, Biopharma

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.